Chainlink Data Streams and DataLink are live on the new Injective EVM Mainnet from launch, providing infrastructure for highly reliable, next-gen applications. The Injective era has officially begun, marking a pivotal moment in decentralized finance (DeFi). Injective has now launched its EVM Mainnet, which has launched a revolutionary blockchain into the market globally. The new […] The post Chainlink News: Chainlink Data Streams Integration Powers InjectiveEVM’s Day One Launch appeared first on Live Bitcoin News.Chainlink Data Streams and DataLink are live on the new Injective EVM Mainnet from launch, providing infrastructure for highly reliable, next-gen applications. The Injective era has officially begun, marking a pivotal moment in decentralized finance (DeFi). Injective has now launched its EVM Mainnet, which has launched a revolutionary blockchain into the market globally. The new […] The post Chainlink News: Chainlink Data Streams Integration Powers InjectiveEVM’s Day One Launch appeared first on Live Bitcoin News.

Chainlink News: Chainlink Data Streams Integration Powers InjectiveEVM’s Day One Launch

Chainlink Data Streams and DataLink are live on the new Injective EVM Mainnet from launch, providing infrastructure for highly reliable, next-gen applications.

The Injective era has officially begun, marking a pivotal moment in decentralized finance (DeFi). Injective has now launched its EVM Mainnet, which has launched a revolutionary blockchain into the market globally. The new network successfully brings to the builders, users, and institutions an environment of MultiVM. In turn, it has real-time transaction speed capabilities. This immediate deployment is fundamentally creating a new future with sophisticated on-chain finance.

High-Speed Oracle Data Drives New DeFi Possibilities

A truly massive development for the entire ecosystem is the instant integration of the Chainlink Data Streams DataLink. These vital services came online immediately on the Injective EVM launch day, November 11, 2025, on the mainnet.

Related Reading: Crypto News: Chainlink Whales Buy 4 Million LINK Despite Weak Market Conditions | Live Bitcoin News

Therefore, this strategic move provides developers with the important infrastructure that they need. They can get started with the building of high-performance applications right away. The network is specifically designed to provide faster transactions as well as extremely low fees.

This is a powerful combination that results in a united development environment. This environment seamlessly supports EVM and WebAssembly (WASM) applications. The Injective EVM also has fast block time at 0.64 seconds and very low transaction costs. The launch is fundamentally growing Injective’s developer ecosystem. It allows developers of the EVM to take advantage of the powerful financial infrastructure and financial primitives of the chain.

The service by Chainlink Data Streams provides essential and low-latency price data. This sophisticated stream of information assists protocols for perpetual futures and other DeFi derivatives enormously. Thus, they are effectively able to compete with traditional centralized exchanges both in performance and reliability.

According to CoinMarketCap data, the live price of Chainlink (LINK) is around $ 16.05 USD. The market capitalization of the token is standing strong at a market cap worth more than $11 billion.

Integration Enables Real-Time, Tamper-Resistant Financial Tools

Given the critical integration, it enables Injective to actively support real-time and low-latency applications. It is connected directly to Chainlink’s decentralized oracle network. This network offers data feeds that are untampered and other important information about markets. This essential infrastructure is made expressly for enabling a host of next-generation dApps.

In essence, Chainlink Data Streams provides real-time and high-performance market data. Developers can therefore develop ultra-fast and extremely easy-to-use dApps right away. Moreover, the integration makes it easy to build reliable applications.

In addition, these advanced tools are able to handle real-time data in an efficient way. Products such as derivatives, by way of example, may, because of this, attain transaction speeds that are competitive with centralized exchanges.

The Data Streams service has a highly available and resilient infrastructure. This ensures that data is always delivered to the Injective EVM securely and reliably. Furthermore, the availability of Data Streams from Day One means no delay in building it for the developer. This follows on from Injective’s past use of Chainlink Price Feeds. Those feeds are used where different user-created derivative markets across the platform are being settled currently.

The post Chainlink News: Chainlink Data Streams Integration Powers InjectiveEVM’s Day One Launch appeared first on Live Bitcoin News.

Market Opportunity
SecondLive Logo
SecondLive Price(LIVE)
$0.00007003
$0.00007003$0.00007003
-11.82%
USD
SecondLive (LIVE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26